The Regulatory Role of Matrix Proteins in Mineralization of Bone

Osteoporosis: Fourth Edition

Volumn , Issue , 2013, Pages 235-255

  Boskey, Adele L ^a   Robey, Pamela Gehron ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Alkaline phosphatase; Bone mineralization; Bone tissue; Collagenous and noncollagenous proteins; Glycoproteins; Glycosaminoglycans (GAGs); Matrix proteins; Nucleator; Osteocalcin; Osteonectin; Periostin; Proteoglycans

Indexed keywords

EID: 84900024853     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-415853-5.00011-X     Document Type: Chapter

References (169)

1. Robey P.G. Normal bone formation: structure. Bone Formation and Repair 1994, 3-12. AAOS, Rosemont, IL. C.T. Brighton, G. Friedlander, J.M. Lane (Eds.).
2. Holmbeck K., Bianco P., Chrysovergis K., Yamada S., Birkedal-Hansen H. MT1-MMP-dependent, apoptotic remodeling of unmineralized cartilage: a critical process in skeletal growth. J Cell Biol 2003, 163(3):661-671.
3. Midura R.J., Midura S.B., Su X., Gorski J.P. Separation of newly formed bone from older compact bone reveals clear compositional differences in bone matrix. Bone 2011, 49(6):1365-1374.
4. Grimal Q., Rus G., Parnell W.J., Laugier P. A two-parameter model of the effective elastic tensor for cortical bone. J Biomech 2011, 44(8):1621-1635.
5. Donnelly E. Methods for assessing bone quality: a review. Clin Orthop Relat Res 2011, 469(8):2128-2138.
6. Hukins D.W.L., Cox A.J., Harries J. EXAFS characterisation of poorly crystalline deposits from biological systems in the presence of highly crystalline material. J Physique 1986, 48:1181-1184.
7. Mahamid J., Aichmayer B., Shimoni E., Ziblat R., Li C., Siegel S., et al. Mapping amorphous calcium phosphate transformation into crystalline mineral from the cell to the bone in zebrafish fin rays. Proc Natl Acad Sci U S A 2010, 107(14):6316-6321.
8. Vashishth D. The role of the collagen matrix in skeletal fragility. Curr Osteoporos Rep 2007, 5(2):62-66.
9. Gordon M.K., Hahn R.A. Collagens. Cell Tissue Res 2010, 339(1):247-257.
10. Brodsky B., Persikov A.V. Molecular structure of the collagen triple helix. Adv Protein Chem 2005, 70:301-339.
11. Traub W., Arad T., Weiner S. Origin of mineral crystal growth in collagen fibrils. Matrix 1992, 12(4):251-255.
12. Hjorten R., Hansen U., Underwood R.A., Telfer H.E., Fernandes R.J., Krakow D., et al. Type XXVII collagen at the transition of cartilage to bone during skeletogenesis. Bone 2007, 41(4):535-542.
13. Allen K.D., Griffin T.M., Rodriguiz R.M., Wetsel W.C., Kraus V.B., Huebner J.L., et al. Decreased physical function and increased pain sensitivity in mice deficient for type IX collagen. Arthritis Rheum 2009, 60(9):2684-2693.
14. Marini J.C., Forlino A., Cabral W.A., Barnes A.M., San Antonio J.D., et al. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat 2007, 28(3):209-221.
15. Blank R.D., Boskey A.L. Genetic collagen diseaes: influence of collagen mutations on structure and mechanical behavior. Collagen: Structure and Mechanics 2008, 447-474. Springer Science and Business Media, LLC, Chapter 16. P. Fratzl (Ed.).
16. Vetter U., Eanes E.D., Kopp J.B., Termine J.D., Robey P.G. Changes in apatite crystal size in bones of patients with osteogenesis imperfecta. Calcif Tissue Int 1991, 49(4):248-250.
17. Fratzl P., Paris O., Klaushofer K., Landis W.J. Bone mineralization in an osteogenesis imperfecta mouse model studied by small-angle x-ray scattering. J Clin Invest 1996, 97(2):396-402.
18. Sweeney S.M., Orgel J.P., Fertala A., McAuliffe J.D., Turner K.R., Lullo Di, et al. Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebrates. J Biol Chem 2008, 283(30):21187-21197.
19. Heinegard D. Proteoglycans and more - from molecules to biology. Int J Exp Pathol 2009, 90(6):575-586.
20. Sandy J.D., Flannery C.R., Boynton R.E., Neame P.J. Isolation and characterization of disulfide-bonded peptides from the three globular domains of aggregating cartilage proteoglycan. J Biol Chem 1990, 265(34):21108-21113.
21. Hardingham T.E. The role of link-protein in the structure of cartilage proteoglycan aggregates. Biochem J 1979, 177(1):237-247.
22. Watanabe H., Yamada Y. Chondrodysplasia of gene knockout mice for aggrecan and link protein. Glycoconj J 2002, 19(4-5):269-273.
23. Moffatt P., Lee E.R., St-Jacques B., Matsumoto K., Yamaguchi Y., Roughley P.J. Hyaluronan production by means of Has2 gene expression in chondrocytes is essential for long bone development. Dev Dyn 2011, 240(2):404-412.
24. Sato T., Kudo T., Ikehara Y., Ogawa H., Hirano T., Kiyohara K., et al. Chondroitin sulfate N-acetylgalactosaminyltransferase 1 is necessary for normal endochondral ossification and aggrecan metabolism. J Biol Chem 2011, 286(7):5803-5812.
25. Bertrand J., Cromme C., Umlauf D., Frank S., Pap T. Molecular mechanisms of cartilage remodelling in osteoarthritis. Int J Biochem Cell Biol 2010, 42(10):1594-1601.
26. Boskey A.L. Hydroxyapatite formation in a synamic gel system: effects of type I collagen, lipids, and proteoglycans. J Phys Chem 1989, 93:1628-1633.
27. Hunter G.K. An ion-exchange mechanism of cartilage calcification. Connect Tissue Res 1987, 16(2):111-120.
28. Chen C.C., Boskey A.L. Mechanisms of proteoglycan inhibition of hydroxyapatite growth. Calcif Tissue Int 1985, 37(4):395-400.
29. Boskey A.L., Marks S.C. Mineral and matrix alterations in the bones of incisors-absent (ia/ia) osteopetrotic rats. Calcif Tissue Int 1985, 37(3):287-292.
30. Kjellen L., Lindahl U. Proteoglycans: structures and interactions. Annu Rev Biochem 1991, 60:443-475.
31. Nakamura M., Sone S., Takahashi I., Mizoguchi I., Echigo S., Sasano Y. Expression of versican and ADAMTS1, 4, and 5 during bone development in the rat mandible and hind limb. J Histochem Cytochem 2005, 53(12):1553-1562.
32. Zhang Y., Cao L., Kiani C., Yang B.L., Hu W., Yang B.B. Promotion of chondrocyte proliferation by versican mediated by G1 domain and EGF-like motifs. J Cell Biochem 1999, 73(4):445-457.
33. Antosz M.E., Bellows C.G., Aubin J.E. Biphasic effects of epidermal growth factor on bone nodule formation by isolated rat calvaria cells in vitro. J Bone Miner Res 1987, 2(5):385-393.
34. Waddington R.J., Langley M.S. Structural analysis of proteoglycans synthesized by mineralizing bone cells in vitro in the presence of fluoride. Matrix Biol 1998, 17(4):255-268.
35. Iozzo R.V., Schaefer L. Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J 2010, 277(19):3864-3875.
36. Schaefer L., Iozzo R.V. Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem 2008, 283(31):21305-21309.
37. Viola M., Karousou E.G., Vigetti D., Genasetti A., Pallotti F., Guidetti G.F., et al. Decorin from different bovine tissues: study of glycosaminoglycan chain by PAGEFS. J Pharm Biomed Anal 2006, 41(1):36-42.
38. von Marschall Z., Fisher L.W. Decorin is processed by three isoforms of bone morphogenetic protein-1 (BMP1). Biochem Biophys Res Commun 2010, 391(3):1374-1378.
39. Raspanti M., Viola M., Forlino A., Tenni R., Gruppi C., Tira M.E. Glycosaminoglycans show a specific periodic interaction with type I collagen fibrils. J Struct Biol 2008, 164(1):134-139.
40. Young M.F., Bi Y., Ameye L., Xu T., Wadhwa S., Heegaard A., et al. Small leucine-rich proteoglycans in the aging skeleton. J Musculoskelet Neuronal Interact 2006, 6(4):364-365.
41. Grzesik W.J., Frazier C.R., Shapiro J.R., Sponseller P.D., Robey P.G., Fedarko N.S. Age-related changes in human bone proteoglycan structure. Impact of osteogenesis imperfecta. J Biol Chem 2002, 277(46):43638-43647.
42. Kalamajski S., Aspberg A., Lindblom K., Heinegard D., Oldberg A. Asporin competes with decorin for collagen binding, binds calcium and promotes osteoblast collagen mineralization. Biochem J 2009, 423(1):53-59.
43. Mochida Y., Parisuthiman D., Pornprasertsuk-Damrongsri S., Atsawasuwan P., Sricholpech M., Boskey A.L., et al. Decorin modulates collagen matrix assembly and mineralization. Matrix Biol 2009, 28(1):44-52.
44. Boskey A.L., Spevak L., Doty S.B., Rosenberg L. Effects of bone CS-proteoglycans, DS-decorin, and DS-biglycan on hydroxyapatite formation in a gelatin gel. Calcif Tissue Int 1997, 61(4):298-305.
45. Sugars R.V., Milan A.M., Brown J.O., Waddington R.J., Hall R.C., Embery G. Molecular interaction of recombinant decorin and biglycan with type I collagen influences crystal growth. Connect Tissue Res 2003, 44(Suppl. 1):189-195.
46. Lorenzo P., Aspberg A., Onnerfjord P., Bayliss M.T., Neame P.J., Heinegard D. Identification and characterization of asporin: a novel member of the leucine-rich repeat protein family closely related to decorin and biglycan. J Biol Chem 2001, 276(15):12201-12211.
47. Hedbom E., Heinegard D. Binding of fibromodulin and decorin to separate sites on fibrillar collagens. J Biol Chem 1993, 268(36):27307-27312.
48. Chakravarti S. Functions of lumican and fibromodulin: lessons from knockout mice. Glycoconj J 2002, 19(4-5):287-293.
49. Goldberg M., Marchadier A., Vidal C., Harichane Y., Kamoun-Goldrat A., Kellermann O., et al. Differential effects of fibromodulin deficiency on mouse mandibular bones and teeth: a micro-CT time course study. Cells Tissues Organs 2011, 194(2-4):205-210.
50. Rehn A.P., Cerny R., Sugars R.V., Kaukua N., Wendel M. Osteoadherin is upregulated by mature osteoblasts and enhances their in vitro differentiation and mineralization. Calcif Tissue Int 2008, 82(6):454-464.
51. Igwe J.C., Gao Q., Kizivat T., Kao W.W., Kalajzic I. Keratocan is expressed by osteoblasts and can modulate osteogenic differentiation. Connect Tissue Res 2011, 52(5):401-407.
52. Raouf A., Ganss B., McMahon C., Vary C., Roughley P.J., Seth A. Lumican is a major proteoglycan component of the bone matrix. Matrix Biol 2002, 21(4):361-367.
53. Yeh J.T., Yeh L.K., Jung S.M., Chang T.J., Wu H.H., Shiu T.F., et al. Impaired skin wound healing in lumican-null mice. Br J Dermatol 2010, 163(6):1174-1180.
54. Nuka S., Zhou W., Henry S.P., Gendron C.M., Schultz J.B., Shinomura T., et al. Phenotypic characterization of epiphycan-deficient and epiphycan/biglycan double-deficient mice. Osteoarthritis Cartilage 2010, 18(1):88-96.
55. Wuthier R.E., Lipscomb G.F. Matrix vesicles: structure, composition, formation and function in calcification. Front Biosci 2012, 17:2812-2902.
56. Bianco P., Fedarko N.S., Bonucci E., Termine J.D., Robey P.G. Acid and alkaline phosphatase activities of bone cells revisited. Proc Int Soc Bioanal Skel Impl 1991, 17-27.
57. Fedde K.N., Blair L., Silverstein J., Coburn S.P., Ryan L.M., Weinstein R.S., et al. Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 1999, 14(12):2015-2026.
58. Yadav M.C., Simao A.M., Narisawa S., Huesa C., McKee M.D., Farquharson C., et al. Loss of skeletal mineralization by the simultaneous ablation of PHOSPHO1 and alkaline phosphatase function: a unified model of the mechanisms of initiation of skeletal calcification. J Bone Miner Res 2011, 26(2):286-297.
59. Whyte M.P. Physiological role of alkaline phosphatase explored in hypophosphatasia. Ann N Y Acad Sci 2010, 1192:190-200.
60. Termine J.D., Kleinman H.K., Whitson S.W., Conn K.M., McGarvey M.L., Martin G.R. Osteonectin, a bone-specific protein linking mineral to collagen. Cell 1981, 26(1Pt1):99-105.
61. Conn K.M., Termine J.D. Matrix protein profiles in calf bone development. Bone 1985, 6(1):33-36.
62. Thomas R., True L.D., Bassuk J.A., Lange P.H., Vessella R.L. Differential expression of osteonectin/SPARC during human prostate cancer progression. Clin Cancer Res 2000, 6(3):1140-1149.
63. Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol 1995, 130(3):503-506.
64. Katsube K., Sakamoto K., Tamamura Y., Yamaguchi A. Role of CCN, a vertebrate specific gene family, in development. Dev Growth Differ 2009, 51(1):55-67.
65. Fisher L.W., Fedarko N.S. Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect Tissue Res 2003, 44(Suppl. 1):33-40.
66. Kapinas K., Kessler C.B., Delany A.M. miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling. J Cell Biochem 2009, 108(1):216-224.
67. Mansergh F.C., Wells T., Elford C., Evans S.L., Perry M.J., Evans M.J., et al. Osteopenia in Sparc (osteonectin)-deficient mice: characterization of phenotypic determinants of femoral strength and changes in gene expression. Physiol Genomics 2007, 32(1):64-73.
68. Boskey A.L., Moore D.J., Amling M., Canalis E., Delany A.M. Infrared analysis of the mineral and matrix in bones of osteonectin-null mice and their wildtype controls. J Bone Miner Res 2003, 18(6):1005-1011.
69. Gruber H.E., Sage E.H., Norton H.J., Funk S., Ingram J., Hanley E.N. Targeted deletion of the SPARC gene accelerates disc degeneration in the aging mouse. J Histochem Cytochem 2005, 53(9):1131-1138.
70. Qin C., Baba O., Butler W.T. Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis. Crit Rev Oral Biol Med 2004, 15(3):126-136.
71. Hankenson K.D., Sweetwyne M.T., Shitaye H., Posey K.L. Thrombospondins and novel TSR-containing proteins, R-spondins, regulate bone formation and remodeling. Curr Osteoporos Rep 2010, 8(2):68-76.
72. Brunner M., Millon-Fremillon A., Chevalier G., Nakchbandi I.A., Mosher D., Block M.R., et al. Osteoblast mineralization requires beta1 integrin/ICAP-1-dependent fibronectin deposition. J Cell Biol 2011, 194(2):307-322.
73. Daculsi G., Pilet P., Cottrel M., Guicheux G. Role of fibronectin during biological apatite crystal nucleation: ultrastructural characterization. J Biomed Mater Res 1999, 47(2):228-233.
74. Tompa P. Unstructural biology coming of age. Curr Opin Struct Biol 2011, 21(3):419-425.
75. Fisher L.W., Torchia D.A., Fohr B., Young M.F., Fedarko N.S. Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. Biochem Biophys Res Commun 2001, 280(2):460-465.
76. Gericke A., Qin C., Sun Y., Redfern R., Redfern D., Fujimoto Y., et al. Different forms of DMP1 play distinct roles in mineralization. J Dent Res 2010, 89(4):355-359.
77. Gaudin-Audrain C., Gallois Y., Pascaretti-Grizon F., Hubert L., Massin P., Basle M.F., et al. Osteopontin is histochemically detected by the AgNOR acid-silver staining. Histol Histopathol 2008, 23(4):469-478.
78. Scatena M., Liaw L., Giachelli C.M. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007, 27(11):2302-2309.
79. Boskey A.L., Spevak L., Paschalis E., Doty S.B., McKee M.D. Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone. Calcif Tissue Int 2002, 71(2):145-154.
80. Shimizu S., Okuda N., Kato N., Rittling S.R., Okawa A., Shinomiya K., et al. Osteopontin deficiency impairs wear debris-induced osteolysis via regulation of cytokine secretion from murine macrophages. Arthritis Rheum 2010, 62(5):1329-1337.
81. Hunter G.K., Goldberg H.A. Nucleation of hydroxyapatite by bone sialoprotein. Proc Natl Acad Sci U S A 1993, 90(18):8562-8565.
82. Huffman N.T., Keightley J.A., Chaoying C., Midura R.J., Lovitch D., Veno P.A., et al. Association of specific proteolytic processing of bone sialoprotein and one acidic glycoprotein-75 with mineralization within biomineralization foci. J Biol Chem 2007, 282(36):26002-26013.
83. Wade-Gueye N.M., Boudiffa M., Laroche N., Vanden-Bossche A., Fournier C., Aubin J.E., et al. Mice lacking bone sialoprotein (BSP) lose bone after ovariectomy and display skeletal site-specific response to intermittent PTH treatment. Endocrinology 2010, 151(11):5103-5113.
84. Boudiffa M., Wade-Gueye N.M., Guignandon A., Vanden-Bossche A., Sabido O., Aubin J.E., et al. Bone sialoprotein deficiency impairs osteoclastogenesis and mineral resorption in vitro. J Bone Miner Res 2010, 25(12):2669-2679.
85. Gorski J.P., Kremer E.A., Chen Y. Bone acidic glycoprotein-75 self-associates to form large macromolecular complexes. Connect Tissue Res 1996, 35(1-4):137-143.
86. Qin C., Brunn J.C., Jones J., George A., Ramachandran A., Gorski J.P., et al. A comparative study of sialic acid-rich proteins in rat bone and dentin. Eur J Oral Sci 2001, 109(2):133-141.
87. Feng J.Q., Huang H., Lu Y., Ye L., Xie Y., Tsutsui T.W., et al. The dentin matrix protein 1 (Dmp1) is specifically expressed in mineralized, but not soft, tissues during development. J Dent Res 2003, 82(10):776-780.
88. Noble B.S. The osteocyte lineage. Arch Biochem Biophys 2008, 473(2):106-111.
89. Ling Y., Rios H.F., Myers E.R., Lu Y., Feng J.Q., Boskey A.L. DMP1 depletion decreases bone mineralization in vivo: an FTIR imaging analysis. J Bone Miner Res 2005, 20(12):2169-2177.
90. Feng J.Q., Ward L.M., Liu S., Lu Y., Xie Y., Yuan B., et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 2006, 38(11):1310-1315.
91. Zhao X., Dittmer K.E., Blair H.T., Thompson K.G., Rothschild M.F., Garrick D.J. A novel nonsense mutation in the DMP1 gene identified by a genome-wide association study is responsible for inherited rickets in Corriedale sheep. PLoS One 2011, 6(7):e21739.
92. Bhatia A., Albazzaz M., Espinoza Orias A.A., Inoue N., Miller L.M., et al. Overexpression of DMP1 accelerates mineralization and alters cortical bone biomechanical properties in vivo. J Mech Behav Biomed Mater 2012, 5(1):1-8.
93. Eapen A., Sundivakkam P., Song Y., Ravindran S., Ramachandran A., Tiruppathi C., et al. Calcium-mediated stress kinase activation by DMP1 promotes osteoblast differentiation. J Biol Chem 2010, 285(47):36339-36351.
94. Yuan G., Wang Y., Gluhak-Heinrich J., Yang G., Chen L., Li T., et al. Tissue-specific expression of dentin sialophosphoprotein (DSPP) and its polymorphisms in mouse tissues. Cell Biol Int 2009, 33(8):816-829.
95. Prasad M., Butler W.T., Qin C. Dentin sialophosphoprotein in biomineralization. Connect Tissue Res 2010, 51(5):404-417.
96. Boskey A.L., Maresca M., Doty S., Sabsay B., Veis A. Concentration-dependent effects of dentin phosphophoryn in the regulation of in vitro hydroxyapatite formation and growth. Bone Miner 1990, 11(1):55-65.
97. Verdelis K., Ling Y., Sreenath T., Haruyama N., MacDougall M., van der Meulen M.C., et al. DSPP effects on in vivo bone mineralization. Bone 2008, 43(6):983-990.
98. Rowe P.S., de Zoysa P.A., Dong R., Wang H.R., White K.E., et al. MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia. Genomics 2000, 67(1):54-68.
99. Boskey A.L., Chiang P., Fermanis A., Brown J., Taleb H., David V., et al. MEPE's diverse effects on mineralization. Calcif Tissue Int 2010, 86(1):42-46.
100. Addison W.N., Nakano Y., Loisel T., Crine P., McKee M.D. MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM. J Bone Miner Res 2008, 23(10):1638-1649.
101. Siggelkow H., Schmidt E., Hennies B., Hufner M. Evidence of downregulation of matrix extracellular phosphoglycoprotein during terminal differentiation in human osteoblasts. Bone 2004, 35(2):570-576.
102. Gowen L.C., Petersen D.N., Mansolf A.L., Qi H., Stock J.L., Tkalcevic G.T., et al. Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem 2003, 278(3):1998-2007.
103. David V., Martin A., Hedge A.M., Rowe P.S. Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator. Endocrinology 2009, 150(9):4012-4023.
104. Confavreux C.B., Levine R.L., Karsenty G. A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms. Mol Cell Endocrinol 2009, 310(1-2):21-29.
105. Yoshikawa Y., Kode A., Xu L., Mosialou I., Silva B.C., Ferron M., et al. Genetic evidence points to an osteocalcin-independent influence of osteoblasts on energy metabolism. J Bone Miner Res 2011, 26(9):2012-2025.
106. Lian J.B., McKee M.D., Todd A.M., Gerstenfeld L.C. Induction of bone-related proteins, osteocalcin and osteopontin, and their matrix ultrastructural localization with development of chondrocyte hypertrophy in vitro. J Cell Biochem 1993, 52(2):206-219.
107. Goyal N., Gupta M., Joshi K., Nagi O.N. Immunohistochemical analysis of ageing and osteoarthritic articular cartilage. J Mol Histol 2010, 41(4-5):193-197.
108. Park J.Y., Kuh S.U., Park H.S., Kim K.S. Comparative expression of matrix-associated genes and inflammatory cytokines-associated genes according to disc degeneration: analysis of living human nucleus pulposus. J Spinal Disord Tech 2011, 24(6):352-357.
109. Salmela E., Alaluusua S., Sahlberg C., Lukinmaa P.L. Tributyltin alters osteocalcin, matrix metalloproteinase 20 and dentin sialophosphoprotein gene expression in mineralizing mouse embryonic tooth in vitro. Cells Tissues Organs 2012, 195(4):287-295.
110. Foresta C., Strapazzon G., De Toni L., Gianesello L., Calcagno A., Pilon C., et al. Evidence for osteocalcin production by adipose tissue and its role in human metabolism. J Clin Endocrinol Metab 2010, 95(7):3502-3506.
111. Patterson-Buckendahl P. Osteocalcin is a stress-responsive neuropeptide. Endocr Regul 2011, 45(2):99-110.
112. Cranenburg E.C., Schurgers L.J., Vermeer C. Vitamin K: the coagulation vitamin that became omnipotent. Thromb Haemost 2007, 98(1):120-125.
113. Baek W.Y., Kim J.E. Transcriptional regulation of bone formation. Front Biosci (Schol Ed) 2011, 3:126-135.
114. Aronow M.A., Gerstenfeld L.C., Owen T.A., Tassinari M.S., Stein G.S., Lian J.B. Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. J Cell Physiol 1990, 143(2):213-221.
115. Bilic-Curcic I., Kronenberg M., Jiang X., Bellizzi J., Mina M., Marijanovic I., et al. Visualizing levels of osteoblast differentiation by a two-color promoter-GFP strategy: type I collagen-GFPcyan and osteocalcin-GFPtpz. Genesis 2005, 43(2):87-98.
116. Boskey A.L., Gadaleta S., Gundberg C., Doty S.B., Ducy P., Karsenty G. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 1998, 23(3):187-196.
117. Murshed M., Schinke T., McKee M.D., Karsenty G. Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol 2004, 165(5):625-630.
118. Julien M., Khoshniat S., Lacreusette A., Gatius M., Bozec A., Wagner E.F., et al. Phosphate-dependent regulation of MGP in osteoblasts: role of ERK1/2 and Fra-1. J Bone Miner Res 2009, 24(11):1856-1868.
119. Kudo A. Periostin in fibrillogenesis for tissue regeneration: periostin actions inside and outside the cell. Cell Mol Life Sci 2011, 68(19):3201-3207.
120. Kii I., Nishiyama T., Li M., Matsumoto K., Saito M., Amizuka N., et al. Incorporation of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture. J Biol Chem 2010, 285(3):2028-2039.
121. Ma D., Zhang R., Sun Y., Rios H.F., Haruyama N., Han X., et al. A novel role of periostin in postnatal tooth formation and mineralization. J Biol Chem 2011, 286(6):4302-4309.
122. Eppell S.J., Tong W., Katz J.L., Kuhn L., Glimcher M.J. Shape and size of isolated bone mineralites measured using atomic force microscopy. J Orthop Res 2001, 19(6):1027-1034.
123. Jahnen-Dechent W., Heiss A., Schafer C., Ketteler M. Fetuin-A regulation of calcified matrix metabolism. Circ Res 2011, 108(12):1494-1509.
124. Gorski J.P. Biomineralization of bone: a fresh view of the roles of non-collagenous proteins. Front Biosci 2012, 17:2598-2621.
125. Golub E.E. Biomineralization and matrix vesicles in biology and pathology. Semin Immunopathol 2011, 33(5):409-417.
126. Kawasaki K., Buchanan A.V., Weiss K.M. Biomineralization in humans: making the hard choices in life. Annu Rev Genet 2009, 43:119-142.
127. Wang L., Nancollas G.H. Pathways to biomineralization and biodemineralization of calcium phosphates: the thermodynamic and kinetic controls. Dalton Trans 2009, (15):2665-2672.
128. Weiner S. Biomineralization: a structural perspective. J Struct Biol 2008, 163(3):229-234.
129. Fulmer M.T., Ison I.C., Hankermayer C.R., Constantz B.R., Ross J. Measurements of the solubilities and dissolution rates of several hydroxyapatites. Biomaterials 2002, 23(3):751-755.
130. Boskey A.L. Amorphous calcium phosphate: the contention of bone. J Dent Res 1997, 76(8):1433-1436.
131. Eanes E.D. Amorphous calcium phosphate. Monogr Oral Sci 2001, 18:130-147.
132. Combes C., Rey C. Amorphous calcium phosphates: synthesis, properties and uses in biomaterials. Acta Biomater 2010, 6(9):3362-3378.
133. Suzuki O. Octacalcium phosphate: osteoconductivity and crystal chemistry. Acta Biomater 2010, 6(9):3379-3387.
134. Grynpas M.D., Omelon S. Transient precursor strategy or very small biological apatite crystals?. Bone 2007, 41(2):162-164.
135. Suzuki A., Ammann P., Nishiwaki-Yasuda K., Sekiguchi S., Asano S., Nagao S., et al. Effects of transgenic Pit-1 overexpression on calcium phosphate and bone metabolism. J Bone Miner Metab 2010, 28(2):139-148.
136. Teixeira C.C., Xiang J., Roy R., Kudrashov V., Binderman I., Mayer-Kuckuk P., et al. Changes in matrix protein gene expression associated with mineralization in the differentiating chick limb-bud micromass culture system. J Cell Biochem 2011, 112(2):607-613.
137. Kim H.J., Delaney J.D., Kirsch T. The role of pyrophosphate/phosphate homeostasis in terminal differentiation and apoptosis of growth plate chondrocytes. Bone 2010, 47(3):657-665.
138. Grabner B., Landis W.J., Roschger P., Rinnerthaler S., Peterlik H., Klaushofer K., et al. Age- and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim). Bone 2001, 29(5):453-457.
139. Traub W., Arad T., Vetter U., Weiner S. Ultrastructural studies of bones from patients with osteogenesis imperfecta. Matrix Biol 1994, 14(4):337-345.
140. Orgel J.P., San Antonio J.D., Antipova O. Molecular and structural mapping of collagen fibril interactions. Connect Tissue Res 2011, 52(1):2-17.
141. Celotti G., Tampieri A., Sprio S., Landi E., Bertinetti L., Martra G., et al. Crystallinity in apatites: how can a truly disordered fraction be distinguished from nanosize crystalline domains?. J Mater Sci Mater Med 2006, 17(11):1079-1087.
142. Glimcher M.J., Krane S.M. The incorporation of radioactive inorganic orthophosphate as organic phosphate by collagen fibrils in vitro. Biochemistry 1964, 3:195-202.
143. Veis A., Schlueter R.J. The macromolecular organization of dentine matrix collagen. I. characterization of dentine collagen. Biochemistry 1964, 3:1650-1657.
144. George A., Veis A. Phosphorylated proteins and control over apatite nucleation, crystal growth, and inhibition. Chem Rev 2008, 108(11):4670-4693.
145. Anderson H.C. Matrix vesicles and calcification. Curr Rheumatol Rep 2003, 5(3):222-226.
146. Genge B.R., Wu L.N., Wuthier R.E. In vitro modeling of matrix vesicle nucleation: synergistic stimulation of mineral formation by annexin A5 and phosphatidylserine. J Biol Chem 2007, 282(36):26035-26045.
147. Boyan B.D., Schwartz Z. 1,25-Dihydroxy vitamin D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60-activated matrix vesicle matrix metalloproteinases. Cells Tissues Organs 2009, 189(1-4):70-74.
148. Simao A.M., Yadav M.C., Narisawa S., Bolean M., Pizauro J.M., Hoylaerts M.F., et al. Proteoliposomes harboring alkaline phosphatase and nucleotide pyrophosphatase as matrix vesicle biomimetics. J Biol Chem 2010, 285(10):7598-7609.
149. Drabek K., van de Peppel J., Eijken M., van Leeuwen J.P. GPM6B regulates osteoblast function and induction of mineralization by controlling cytoskeleton and matrix vesicle release. J Bone Miner Res 2011, 26(9):2045-2051.
150. Christoffersen J., Landis W.J. A contribution with review to the description of mineralization of bone and other calcified tissues in vivo. Anat Rec 1991, 230(4):435-450.
151. Silver F.H., Landis W.J. Deposition of apatite in mineralizing vertebrate extracellular matrices: a model of possible nucleation sites on type I collagen. Connect Tissue Res 2011, 52(3):242-254.
152. Sfeir C., Lee D., Li J., Zhang X., Boskey A.L., Kumta P.N. Expression of phosphophoryn is sufficient for the induction of matrix mineralization by mammalian cells. J Biol Chem 2011, 286(23):20228-20238.
153. Boskey A.L., Maresca M., Armstrong A.L., Ehrlich M.G. Treatment of proteoglycan aggregates with physeal enzymes reduces their ability to inhibit hydroxyapatite proliferation in a gelatin gel. J Orthop Res 1992, 10(3):313-319.
154. O'Young J., Liao Y., Xiao Y., Jalkanen J., Lajoie G., Karttunen M., et al. Matrix Gla protein inhibits ectopic calcification by a direct interaction with hydroxyapatite crystals. J Am Chem Soc 2011, 133(45):18406-18412.
155. Rees S.G., Wassell D.T., Shellis R.P., Embery G. Effect of serum albumin on glycosaminoglycan inhibition of hydroxyapatite formation. Biomaterials 2004, 25(6):971-977.
156. Weissen-Plenz G., Nitschke Y., Rutsch F. Mechanisms of arterial calcification: spotlight on the inhibitors. Adv Clin Chem 2008, 46:263-293.
157. Moradian-Oldak J., Weiner S., Addadi L., Landis W.J., Traub W. Electron imaging and diffraction study of individual crystals of bone, mineralized tendon and synthetic carbonate apatite. Connect Tissue Res 1991, 25(3-4):219-228.
158. Wang X., Wu C., Tao K., Zhao K., Wang J., Xu H., et al. Influence of ovalbumin on CaCO3 precipitation during in vitro biomineralization. J Phys Chem B 2010, 114(16):5301-5308.
159. Hanein D., Geiger B., Addadi L. Fibronectin adsorption to surfaces of hydrated crystals: an analysis of the importance of bound water in protein-substrate interactions. Langmuir 1993, 9:1058-1065.
160. Aizenberg J., Albeck S., Weiner S., Addadi L. Crystal-protein interactions studied by overgrowth of calcite on biogenic skeletal elements. J Crystal Growth 1994, 142:156-164.
161. Sikiric M.D., Furedi-Milhofer H. The influence of surface active molecules on the crystallization of biominerals in solution. Adv Colloid Interface Sci 2006, 128-130:135-158.
162. Yang Y., Mkhonto D., Cui Q., Sahai N. Theoretical study of bone sialoprotein in bone biomineralization. Cells Tissues Organs 2011, 194(2-4):182-187.
163. Hanein D., Sabanay H., Addadi L., Geiger B. Selective interactions of cells with crystal surfaces. Implications for the mechanism of cell adhesion. J Cell Sci 1993, 104(Pt 2):275-288.
164. Hunter G.K., O'Young J., Grohe B., Karttunen M., Goldberg H.A. The flexible polyelectrolyte hypothesis of protein-biomineral interaction. Langmuir 2010, 26(24):18639-18646.
165. Azzopardi P.V., O'Young J., Lajoie G., Karttunen M., Goldberg H.A., Hunter G.K. Roles of electrostatics and conformation in protein-crystal interactions. PLoS One 2010, 5(2):e9330.
166. Silverman L., Boskey A.L. Diffusion systems for evaluation of biomineralization. Calcif Tissue Int 2004, 75(6):494-501.
167. Debhardt D.T., Guo X. Osteopontin: a protein with diverse functions. FASEB J 1993, 7:1475-1482.
168. Fisher L.W., McBride O.W., Termine J.D., Young M.F. Human bone sialoprotein: deduced protein sequence and chromosoma location. J Biol Chem 1990, 265:2347-2351.
169. Hauchska P.V., Carr S.A. Calcium dependent alpha helical structure in osteocalcin. Biochem 1982, 21:2538-2547.